Previous Article | Next Article 
Journal of Clinical Microbiology, April 1999, p. 1150-1153, Vol. 37, No. 4
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Human Herpesvirus 8 Seroprevalence and Evaluation of Nonsexual
Transmission Routes by Detection of DNA in Clinical Specimens from
Human Immunodeficiency Virus-Seronegative Patients from Central and
Southern Italy, with and without Kaposi's Sarcoma
Paola
Cattani,1,*
Maria
Capuano,2
Francesca
Cerimele,1
Ilaria Lesnoni
La
Parola,2
Rosaria
Santangelo,1
Cinzia
Masini,2
Decio
Cerimele,2 and
Giovanni
Fadda1
Institute of
Microbiology1 and Institute of
Dermatology,2 Università Cattolica del
Sacro Cuore, 00168 Rome, Italy
Received 23 March 1998/Returned for modification 28 May
1998/Accepted 15 January 1999
In order to investigate the seroprevalence of human herpesvirus 8 (HHV-8) infection in central and southern Italy, sera from human
immunodeficiency virus (HIV)-seronegative subjects, with and without
Kaposi's sarcoma (KS), were analyzed by immunofluorescence assay,
using BC-3, a cell line latently infected with HHV-8. High titers of
antibody against HHV-8 lytic and latent antigens were detected in all
50 KS patients studied, while in 50 HIV-seronegative subjects without
KS, 32 (64%) were found positive for HHV-8 antibodies. Titers in the
sera of these patients were lower than those for KS patients. This data
suggests that HHV-8 infection is not restricted to KS patients and that
the prevalence of HHV-8 infection in the general population may be
correlated with differing rates of prevalence of KS in different parts
of the world. In view of these findings, possible nonsexual
transmission routes were evaluated. Nested PCR was used to test for the
presence of HHV-8 DNA in saliva, urine, and tonsillar swabs from KS and
non-KS patients. In KS patients, 14 out of 32 tonsillar swabs (43.7%),
11 out of 24 saliva samples (45.8%), and just 2 out of 24 urine
samples (8.3%) tested positive for HHV-8 DNA. In the control group, on
the contrary, none of the 20 saliva and 20 urine specimens was positive
for HHV-8 DNA; only 1 out of 22 tonsillar swabs gave a positive result. This data supports the hypothesis that HHV-8 infects the general population in a latent form. The reactivation of viral infection may
result in salivary shedding of HHV-8, contributing to viral spread by
nonsexual transmission routes.
*
Corresponding author. Mailing address: Paola Cattani,
Istituto di Microbiologia, Università Cattolica del Sacro Cuore,
Largo F. Vito 1, 00168 Rome, Italy. Phone: 39-6-30154964. Fax:
39-6-3051152. E-mail: p_cattani{at}iol.it.
Journal of Clinical Microbiology, April 1999, p. 1150-1153, Vol. 37, No. 4
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Dalton-Griffin, L., Wilson, S. J., Kellam, P.
(2009). X-Box Binding Protein 1 Contributes to Induction of the Kaposi's Sarcoma-Associated Herpesvirus Lytic Cycle under Hypoxic Conditions. J. Virol.
83: 7202-7209
[Abstract]
[Full Text]
-
Miller, C. S., Berger, J. R., Mootoor, Y., Avdiushko, S. A., Zhu, H., Kryscio, R. J.
(2006). High prevalence of multiple human herpesviruses in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy.. J. Clin. Microbiol.
44: 2409-2415
[Abstract]
[Full Text]
-
Teo, C.G.
(2006). Conceptual Emergence of Human Herpesvirus 8 (Kaposi's Sarcoma-associated Herpesvirus) as an Oral Herpesvirus. ADR
19: 85-90
[Abstract]
[Full Text]
-
Trento, E., Castilletti, C., Ferraro, C., Lesnoni La Parola, I., Mussi, A., Muscardin, L., Bordignon, V., D'Agosto, G., Amantea, A., Mastroianni, A., Ameglio, F., Fluhr, J., Cordiali-Fei, P.
(2005). Human Herpesvirus 8 Infection in Patients With Cutaneous Lymphoproliferative Diseases. Arch Dermatol
141: 1235-1242
[Abstract]
[Full Text]
-
Miller, C. S., Avdiushko, S. A., Kryscio, R. J., Danaher, R. J., Jacob, R. J.
(2005). Effect of Prophylactic Valacyclovir on the Presence of Human Herpesvirus DNA in Saliva of Healthy Individuals after Dental Treatment. J. Clin. Microbiol.
43: 2173-2180
[Abstract]
[Full Text]
-
Moosa, M.R.
(2005). Kaposi's sarcoma in kidney transplant recipients: a 23-year experience. QJM
98: 205-214
[Abstract]
[Full Text]
-
Santos-Fortuna, E., Caterino-de-Araujo, A.
(2005). Confirming Shedding of Human Herpesvirus 8 in Urine from Infected Patients in Brazil. J. Clin. Microbiol.
43: 1008-1008
[Full Text]
-
Beyari, M. M., Hodgson, T. A., Kondowe, W., Molyneux, E. M., Scully, C. M., Porter, S. R., Teo, C. G.
(2004). Genotypic Profile of Human Herpesvirus 8 (Kaposi's Sarcoma-Associated Herpesvirus) in Urine. J. Clin. Microbiol.
42: 3313-3316
[Abstract]
[Full Text]
-
Dourmishev, L. A., Dourmishev, A. L., Palmeri, D., Schwartz, R. A., Lukac, D. M.
(2003). Molecular Genetics of Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Epidemiology and Pathogenesis. Microbiol. Mol. Biol. Rev.
67: 175-212
[Abstract]
[Full Text]
-
Ablashi, D. V., Chatlynne, L. G., Whitman, J. E. Jr., Cesarman, E.
(2002). Spectrum of Kaposi's Sarcoma-Associated Herpesvirus, or Human Herpesvirus 8, Diseases. Clin. Microbiol. Rev.
15: 439-464
[Abstract]
[Full Text]
-
Cattani, P., Capuano, M., Graffeo, R., Ricci, R., Cerimele, F., Cerimele, D., Nanni, G., Fadda, G.
(2001). Kaposi's Sarcoma Associated with Previous Human Herpesvirus 8 Infection in Kidney Transplant Recipients. J. Clin. Microbiol.
39: 506-508
[Abstract]
[Full Text]